Mortality Among African American Women With Sarcoidosis: Data From The Black Women's Health Study

Abstract

Rationale Sarcoidosis is a chronic systemic granulomatous disease of unknown etiology that disproportionately affects black females. Few studies have specifically addressed causes of death in this population. Objectives To assess rates and causes of death among women with sarcoidosis in a prospective cohort study of U.S. black women. Methods The Black Women’s Health Study is a follow-up study of 59,000 U.S. black women aged 21–69 (median age 38) at entry in 1995. Data on demographic and lifestyle factors and medical conditions, including sarcoidosis, were obtained through biennial questionnaires. Deaths and causes of death from 1995 through 2009 among study subjects were identified from National Death Index data. Measurements We assessed mortality rates among women with and without a history of sarcoidosis. Poisson regression models were used to estimate age-adjusted mortality rates. Cox proportional-hazards models were used to estimate hazard ratios for mortality and 95% confidence intervals (95% CI). Main Results A total of 121 deaths occurred among 1,192 women with a history of sarcoidosis and 2813 deaths among women without the diagnosis. Mortality was greater at every age among women with sarcoidosis and the overall multivariable-adjusted hazard ratio was 2.44 (95% CI 2.03–2.93, p<0.0001). Of the deaths among women with sarcoidosis, 24.7% were directly attributable to sarcoidosis. Conclusions In the Black Women’s Health Study, women with sarcoidosis were more than twice as likely to die as women without the disease, with many of the deaths directly attributable to sarcoidosis. Sarcoidosis is an important cause of premature death among black women with the disease.

Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota

“…This is in contrast to previous reports that observed an approximately 2-fold increased rate of mortality (4, 10). This discrepancy may reflect differences in management of sarcoidosis in different regions or the difference of severity and outcome of sarcoidosis across ethnic groups (11, 12).…”

Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions

“…The authors evaluated sarcoidosis-related mortality compared with the general population, the impact of the most prevalent sarcoidosis-related comorbid conditions, and geographical differences within France. They found that deaths were higher and at younger ages among sarcoidosis patients than among the general population, confirming previous findings from the USA [25,26]. Women died less frequently than men, but the average age at death was similar for both sexes.…”

Epidemiology of Sarcoidosis 1946-2013

“…This is in contrast to the report of a significant increase in the mortality rate from a British population-based study, with hazard ratio of 2.09 (95% CI, 1.59–2.74), 14 and an African-American female prospective cohort study, with hazard ratio of 2.44 (95% CI, 2.03–2.93). 23 This discrepancy may reflect differences in management in different geographical regions or the difference of sarcoidosis severity among different ethnic groups. For example, a coding-based study using the U.S. death certificates demonstrated that the age-adjusted mortality rates differed by sex and ethnic groups.…”